These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Idiopathic inflammatory myopathies from the viewpoint of a neurologist]. Shimizu J Brain Nerve; 2013 Nov; 65(11):1269-74. PubMed ID: 24200604 [TBL] [Abstract][Full Text] [Related]
43. Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of Rheumatology. Gómez GN; Pérez N; Braillard Poccard A; Gómez RA; Costi AC; García MA; Viola M; Benitez A; Aciar MM; Crespo Espíndola M; Yucra D; Cosatti MA; Pisoni C; Capelusnik D; Lojo MN; Barrios BI; Rivero M; Kisluk B; Granel A Clin Rheumatol; 2021 Nov; 40(11):4473-4483. PubMed ID: 34159491 [TBL] [Abstract][Full Text] [Related]
46. Comparison among ACR1997, SLICC and the new EULAR/ACR classification criteria in childhood-onset systemic lupus erythematosus. Rodrigues Fonseca A; Felix Rodrigues MC; Sztajnbok FR; Gerardin Poirot Land M; Knupp Feitosa de Oliveira S Adv Rheumatol; 2019 May; 59(1):20. PubMed ID: 31092290 [TBL] [Abstract][Full Text] [Related]
48. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies. Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379 [TBL] [Abstract][Full Text] [Related]
49. External Validation and Evaluation of Adding MRI or Extended Myositis Antibody Panel to the 2017 EULAR/ACR Myositis Classification Criteria. Luu Q; Day J; Hall A; Limaye V; Major G ACR Open Rheumatol; 2019 Sep; 1(7):462-468. PubMed ID: 31777826 [TBL] [Abstract][Full Text] [Related]
50. Validation of the 2019 ACR/EULAR classification criteria of systemic lupus erythematosus in 100 Japanese patients: a real-world setting analysis. Suda M; Kishimoto M; Ohde S; Okada M Clin Rheumatol; 2020 Jun; 39(6):1823-1827. PubMed ID: 32052228 [TBL] [Abstract][Full Text] [Related]
51. In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment. Adamichou C; Nikolopoulos D; Genitsaridi I; Bortoluzzi A; Fanouriakis A; Papastefanakis E; Kalogiannaki E; Gergianaki I; Sidiropoulos P; Boumpas DT; Bertsias GK Ann Rheum Dis; 2020 Feb; 79(2):232-241. PubMed ID: 31704720 [TBL] [Abstract][Full Text] [Related]
52. Inflammatory myopathies: evaluation and management. Greenberg SA Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525 [TBL] [Abstract][Full Text] [Related]
53. Detection of myositis-specific antibodies. Vulsteke JB; De Langhe E; Claeys KG; Dillaerts D; Poesen K; Lenaerts J; Westhovens R; Van Damme P; Blockmans D; De Haes P; Bossuyt X Ann Rheum Dis; 2019 Jan; 78(1):e7. PubMed ID: 29371203 [No Abstract] [Full Text] [Related]
54. Comparative analysis of the 2016 ACR-EULAR and the 2002 AECG classification criteria for Sjögren's syndrome: Findings from the NIH cohort. Billings M; Amin Hadavand M; Alevizos I Oral Dis; 2018 Mar; 24(1-2):184-190. PubMed ID: 29480635 [TBL] [Abstract][Full Text] [Related]
55. 2019-EULAR/ACR classification criteria domains at diagnosis: predictive factors of long-term damage in systemic lupus erythematosus. Insfrán CE; Aikawa NE; Pasoto SG; Filho DMN; Formiga FFC; Pitta AC; Borba EF; Ribeiro CT; Silva CA; Bonfa E Clin Rheumatol; 2022 Apr; 41(4):1079-1085. PubMed ID: 34782939 [TBL] [Abstract][Full Text] [Related]
56. [Recent Developments in Myositis Syndromes]. Genth E Dtsch Med Wochenschr; 2018 Oct; 143(20):1472-1476. PubMed ID: 30286497 [TBL] [Abstract][Full Text] [Related]
57. Idiopathic inflammatory myopathies in childhood: a brief review of 27 cases. Lorenzoni PJ; Scola RH; Kay CS; Prevedello PG; Espíndola G; Werneck LC Pediatr Neurol; 2011 Jul; 45(1):17-22. PubMed ID: 21723454 [TBL] [Abstract][Full Text] [Related]
58. [Diagnosis of Idiopathic Inflammatory Myopathy: A Muscle Pathology Perspective]. Inoue M; Nishino I Brain Nerve; 2016 Dec; 68(12):1431-1441. PubMed ID: 27916753 [TBL] [Abstract][Full Text] [Related]
60. Editorial on "Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD study". Roy D Int J Rheum Dis; 2023 Oct; 26(10):1904-1907. PubMed ID: 37807616 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]